Co-Founder and Executive Director at Psychedelic Science Funders Collaborative - San Francisco, California, United States
Our world today is experiencing epidemic levels of mental illness. Existing psychiatric treatments fail to address the suffering of the hundreds of millions of people worldwide affected by conditions such as PTSD, depression, and addiction. Emerging research indicates that psychedelic medicine has the potential to be a breakthrough in treating these and other conditions. The Psychedelic Science Funders Collaborative (PSFC), a 501(c)(3) nonprofit, supports research on and clinical trials of physician-prescribed psychedelic medicines and patient access to these treatments. PSFC was born in 2017 out of a realization that psychedelic medicine has the potential to make an enormous impact and has an achievable path to regulatory approval, but has been systemically underfunded.